This transaction follows Pfizers recent effort to rebuild its obesity portfolio after discontinuing three previous GLP-1 candidates due to issues such as elevated liver enzymes or insufficient Phase 1 data
(PubMed) Iyer RN, Khan AA, Gupta A, Vajifdar BU, Lokhandwala YY
How Dietary Supplements are Regulated The Food and Drug Administrations (FDA) Center for Food Safety and Applied Nutrition (CFSAN) is the division responsible for overseeing dietary supplements, as these products are regulated as food under United States (U.S.) law
Effect of exogenous spermidine on osmotic adjustment, antioxidant enzymes activity, and gene expression of gladiolus gandavensis seedlings under salt stress
Inclusion and exclusion criteria The study included adults aged 18 to 65 years who were initiating GLP-1 receptor agonist therapy (semaglutide), had acne, HS, or quantifiable sebaceous gland activity (measured by sebumetry in g/cm), were willing to attend all scheduled follow-up visits, and could provide informed written consent
Summary: Microdosing GLP-1 for Hashimoto's is an unapproved, off-label practice lacking clinical evidence, and the NHS does not recommend GLP-1 receptor agonists for thyroid conditions without concurrent type 2 diabetes or obesity meeting specific criteria
.png)
